World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
32355
World Ranking
18628
National Ranking
9280

Steven M. Rowe publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Steven M. Rowe sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 390 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Steven M. Rowe D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Steven M. Rowe sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 76 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Steven M. Rowe is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily falls within the field of Medicine, with a particular focus on Pulmonary and Respiratory Medicine.

The scientist has contributed extensively to the study of cystic fibrosis and related respiratory disorders. Their work encompasses several subfields, including Molecular Biology, Physiology, Epidemiology, and Emergency Medical Services.

The recent papers associated with Steven M. Rowe cover topics in respiratory medicine and cystic fibrosis, including:

  • Human distal airways contain a multipotent secretory cell that can regenerate alveoli (2022, Nature)
  • A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele (2021, American Journal of Respiratory and Critical Care Medicine)
  • Triple Therapy for Cystic Fibrosis Phe508del -Gating and -Residual Function Genotypes (2021, New England Journal of Medicine)
  • Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist (2023, Journal of Clinical Investigation)
  • Disease modification and biomarker development in Parkinson disease (2020, Neurology)

Steven M. Rowe frequently collaborates with other researchers in the field. Notable frequent co-authors include:

  • George M. Solomon
  • David P. Nichols
  • Scott H. Donaldson
  • Guillermo J. Tearney
  • Shah S. Hussain

Their publications appear regularly in several scientific journals, predominantly:

  • Journal of Cystic Fibrosis
  • American Journal of Respiratory and Critical Care Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • American Journal of Physiology-Lung Cellular and Molecular Physiology

Research topics extensively covered by Steven M. Rowe include:

  • Cystic Fibrosis Research Advances
  • Neonatal Respiratory Health Research
  • Tracheal and airway disorders
  • Asthma and respiratory diseases
  • Pediatric health and respiratory diseases
  • Respiratory viral infections research
  • Dysphagia Assessment and Management

Best Publications

  • A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

    Bonnie W. Ramsey;Jane Davies;N. Gerard McElvaney;Elizabeth Tullis

  • Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

    Jennifer L Taylor-Cousar;Anne Munck;Edward F McKone;Cornelis K van der Ent

  • Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

    Peter G. Middleton;Marcus A. Mall;Pavel Dřevínek;Larry C. Lands

  • Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation : a double-blind, randomised, phase 3 trial

    Harry G M Heijerman;Edward F McKone;Damian G Downey;Eva Van Braeckel

  • A revised airway epithelial hierarchy includes CFTR-expressing ionocytes

    Daniel T. Montoro;Adam L. Haber;Moshe Biton;Moshe Biton;Vladimir Vinarsky

  • Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

    Frank J. Accurso;Steven M. Rowe;J. P. Clancy;Michael P. Boyle

  • Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

    J. P. Clancy;Steven M. Rowe;Frank J. Accurso;Moira L. Aitken

  • VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

    Dominic Keating;Gautham Marigowda;Lucy Burr;Cori Daines

  • The future of cystic fibrosis care: a global perspective

    Scott C Bell;Marcus A Mall;Hector Gutierrez;Milan Macek

  • Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis

    Steven M. Rowe;Sonya L. Heltshe;Sonya L. Heltshe;Tanja Gonska;Scott H. Donaldson

  • Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

    Steven M. Rowe;Cori Daines;Felix C. Ringshausen;Eitan Kerem

  • A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.

    Amit Gaggar;Patricia L. Jackson;Brett D. Noerager;Philip J. O’Reilly

  • A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial

    Michael P Boyle;Scott C Bell;Michael W Konstan;Susanna A McColley

  • Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

    Eitan Kerem;Michael W Konstan;Kris De Boeck;Frank J Accurso

  • VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

    Jane C. Davies;Samuel M. Moskowitz;Cynthia Brown;Alexander Horsley

  • A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation

    Robert J. Snelgrove;Robert J. Snelgrove;Patricia L. Jackson;Matthew T. Hardison;Brett D. Noerager

  • A Foodborne Outbreak of Gastroenteritis Associated with Norwalk-like Viruses: First Molecular Traceback to Deli Sandwiches Contaminated during Preparation

    Nicholas A. Daniels;David A. Bergmire-Sweat;Kellogg J. Schwab;Kellogg J. Schwab;Kate A. Hendricks

  • Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.

    Mark T Dransfield;Steven M Rowe;James E Johnson;William C Bailey

  • “CFTR Modulator Theratyping: Current Status, Gaps and Future Directions”

    John Paul Clancy;Calvin U. Cotton;Scott H. Donaldson;George M. Solomon

  • Cystic Fibrosis Transmembrane Regulator Correctors and Potentiators

    Steven M. Rowe;Alan S. Verkman

Frequent Co-Authors

John P. Clancy
John P. Clancy Cystic Fibrosis Foundation
Eric J. Sorscher
Eric J. Sorscher Emory University
Mark T. Dransfield
Mark T. Dransfield University of Alabama at Birmingham
Michael W. Konstan
Michael W. Konstan Case Western Reserve University
Bonnie W. Ramsey
Bonnie W. Ramsey University of Washington
Amit Gaggar
Amit Gaggar University of Alabama at Birmingham
Marcus A. Mall
Marcus A. Mall Charité - University Medicine Berlin
Isabelle Sermet-Gaudelus
Isabelle Sermet-Gaudelus Necker-Enfants Malades Hospital
Felix Ratjen
Felix Ratjen University of Toronto
David M. Bedwell
David M. Bedwell University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in the healthcare sector but seeking alternative pathways or flexibility, there are several related online degrees and career options available. These programs can provide faster entry into the workforce or advancement for existing professionals.

If you’re considering nursing, online lpn programs offer a streamlined route to become a Licensed Practical Nurse, often with flexible schedules ideal for busy students. For those wishing to specialize, fast track mental health nursing programs allow registered nurses to quickly earn a master’s degree and move into high-demand psychiatric and mental health roles.

Not all careers in healthcare require a medical degree. Administrative roles are growing rapidly, with the best online mha programs supporting advancement into leadership and management positions. Affordability is also important—explore masters in healthcare administration cost comparisons to find programs suited to your budget and career goals.

These options provide diverse pathways for those passionate about healthcare, whether through direct patient care or administrative leadership.

Best Scientists Citing Steven M. Rowe

Trending Scientists

Recently Published Articles